Group Health Plan Coverage Mandate for SARS-CoV-2, COVID-19, and Serology Testing | Practical Law
A Practice Note addressing COVID-19 legislation that required group health plans and health insurers to provide coverage for certain items and services related to detecting SARS-CoV-2 (the virus that causes COVID-19) or diagnosing COVID-19. This resource addresses statutory and regulatory provisions relating to the coverage mandate for COVID-19 testing, and implementing guidance from the federal administrative agencies.